Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the antiviral drug. There were no fatalities reported during the study
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
The entire integration and transition of the brands is expected to be completed by March 2022
MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India
Key takeaways of recent quarter & conference call highlights
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
It would be the first protein-based alternative available in Israel
Glenmark’s current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 46 ANDA’s pending approval with the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
